|
Volumn 40, Issue 10, 2000, Pages 1223-1227
|
Leukapheresis components may be cryoprserved at high cell concentrations without additional loss of HPC function
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
AUTOTRANSPLANTATION;
BLOOD COMPONENT;
CELL FUNCTION;
CELL PROLIFERATION;
CELL VIABILITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRYOPRESERVATION;
GRANULOCYTE TRANSFUSION;
HEMATOPOIESIS;
HEMATOPOIETIC STEM CELL;
HUMAN;
LEUKAPHERESIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
THAWING;
THROMBOCYTE TRANSFUSION;
BLOOD STORAGE;
CELL SURVIVAL;
COMPARATIVE STUDY;
CYTOLOGY;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
PHYSIOLOGY;
BLOOD PRESERVATION;
CELL SURVIVAL;
CRYOPRESERVATION;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
LEUKAPHERESIS;
|
EID: 0033623322
PISSN: 00411132
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1537-2995.2000.40101223.x Document Type: Article |
Times cited : (23)
|
References (19)
|